Titanate nanoribbon-based nanobiohybrid for potential applications in regenerative medicine - Université de Bourgogne Accéder directement au contenu
Article Dans Une Revue RSC Advances Année : 2022

Titanate nanoribbon-based nanobiohybrid for potential applications in regenerative medicine

Résumé

Nanoparticles capable of mimicking natural tissues represent a major technological advancement in regenerative medicine. In this pilot study, the development of a new nanohybrid composed of titanate nanoribbons to mimic the extracellular matrix is reported. During the first phase, nanoribbons were synthesized by hydrothermal treatment. Subsequently, titanate nanoribbons were functionalized by heterobifunctional polyethylene-glycol (PEG) to graft type I collagen on their surface. Biological properties of this new nanobiohybrid such as cytotoxicity to cardiac cells and platelet aggregation ability were evaluated. The so-formed nanobiohybrid permits cellular adhesion and proliferation favoring fine cardiac tissue healing and regeneration.
Fichier principal
Vignette du fichier
d2ra04753e.pdf (3.44 Mo) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-03782926 , version 1 (21-09-2022)

Identifiants

Citer

Lionel Maurizi, Vanessa Bellat, Mathieu Moreau, Emmanuel de Maistre, Julien Boudon, et al.. Titanate nanoribbon-based nanobiohybrid for potential applications in regenerative medicine. RSC Advances, 2022, 12 (41), pp.26875-26881. ⟨10.1039/D2RA04753E⟩. ⟨hal-03782926⟩
54 Consultations
22 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More